Finding miRNA targeting PI3K/Akt/mTOR signaling pathway in human breast cancer cells
Publish place: 12th International Congress on Breast Cancer
Publish Year: 1394
نوع سند: مقاله کنفرانسی
زبان: English
View: 436
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
ICBCMED12_203
تاریخ نمایه سازی: 2 تیر 1397
Abstract:
Background: breast cancer is the first common cancer among women worldwide. One of the major signaling pathways playing a role in the onset and progression of the disease is PI3K/Akt/mTOR, which is inhibited by PTEN. miRNAs are small non-coding molecules that regulate the expression of their targets by inhibition or suppression, and thus their dysregulated expression results in the development of cancer. Materials and methods: using various software applications predicting miRNAs, miR-144 was selected as the inhibitor of PTEN. The expression of miR-144 and PTEN has been evaluated by GEO microarray data, GSE57515 and GSE60716 in breast cancer cell lines and patient samples respectively. Results: PTEN and miR-144 expression analysis showed decreased levels of PTEN in patient samples and increased levels of miR-144 in breast cancer cell lines Conclusion: The results showed that the expression of PTEN and miR-144 was inversely correlated in more breast cancer metastatic cell lines indicating inhibitory effects of miR-144 on PTEN. Therefore, miR- 144 can probably be used in invasive and metastatic cancers as a biomarker either alone or in conjunctionwith other markers.
Keywords:
Authors
Vahid Kia
Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Vahedeh Hosseini
Department of Medical Biotechnology and Nanotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Samira Mohammadi-Yeganeh
Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran